Unity Biotechnology (UBX) Short Interest Ratio & Short Volume $0.96 -0.01 (-1.04%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Unity Biotechnology Short Interest DataUnity Biotechnology (UBX) has a short interest of 258,400 shares, representing 1.68% of the float (the number of shares available for trading by the public). This marks a -10.15% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.6, indicating that it would take 4.6 days of the average trading volume of 66,495 shares to cover all short positions.Current Short Interest258,400 sharesPrevious Short Interest287,600 sharesChange Vs. Previous Month-10.15%Dollar Volume Sold Short$320,416.00Short Interest Ratio4.6 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares16,850,000 sharesFloat Size15,370,000 sharesShort Percent of Float1.68%Today's Trading Volume120,479 sharesAverage Trading Volume66,495 sharesToday's Volume Vs. Average181% Short Selling Unity Biotechnology? Sign up to receive the latest short interest report for Unity Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUBX Short Interest Over TimeUBX Days to Cover Over TimeUBX Percentage of Float Shorted Over Time Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Unity Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024258,400 shares $320,416.00 -10.2%1.7%4.6 $1.24 11/15/2024287,600 shares $347,996.00 -5.1%1.9%5.7 $1.21 10/31/2024303,000 shares $412,080.00 -0.9%2.0%6.2 $1.36 10/15/2024305,700 shares $427,980.00 -1.6%2.0%7.5 $1.40 9/30/2024310,700 shares $456,729.00 +3.0%2.0%7.9 $1.47 9/15/2024301,800 shares $434,592.00 -8.9%2.0%7.4 $1.44 Get the Latest News and Ratings for UBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unity Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024331,200 shares $539,856.00 +3.7%2.2%6.5 $1.63 8/15/2024319,500 shares $450,495.00 +5.5%2.1%5.7 $1.41 7/31/2024303,000 shares $463,590.00 -2.3%2.0%5.4 $1.53 7/15/2024310,100 shares $483,756.00 -3.8%2.0%5.4 $1.56 6/30/2024322,200 shares $434,970.00 0.0%2.1%5.4 $1.35 6/15/2024322,300 shares $460,889.00 -3.0%2.1%5.1 $1.43 5/31/2024332,400 shares $515,220.00 +7.1%2.2%5.5 $1.55 5/15/2024310,300 shares $474,759.00 -6.1%2.0%3.7 $1.53 4/30/2024330,400 shares $508,816.00 +8.4%2.2%3.8 $1.54 4/15/2024304,800 shares $457,200.00 -0.8%2.0%3.4 $1.50 3/31/2024307,200 shares $503,808.00 +5.4%2.0%3.4 $1.64 3/15/2024291,600 shares $437,400.00 +0.3%1.9%2.7 $1.50 2/29/2024290,600 shares $531,798.00 -9.2%1.9%2.6 $1.83 2/15/2024320,000 shares $636,800.00 +4.5%2.1%3.4 $1.99 1/31/2024306,100 shares $529,553.00 -0.3%2.0%3.1 $1.73 1/15/2024307,100 shares $571,206.00 -21.4%2.0%3.2 $1.86 12/31/2023390,700 shares $754,051.00 -15.6%N/A0 $1.93 12/15/2023463,100 shares $791,901.00 -7.7%3.1%5.5 $1.71 11/30/2023501,900 shares $963,648.00 -12.3%3.8%6.9 $1.92 11/15/2023572,500 shares $1.05 million -11.9%4.3%9.1 $1.83 10/31/2023649,600 shares $1.29 million +3.0%4.9%12.8 $1.99 10/15/2023630,900 shares $1.10 million -6.0%4.8%10.3 $1.75 9/30/2023670,900 shares $1.61 million -2.8%5.1%9.7 $2.40 9/15/2023690,400 shares $1.76 million -6.0%5.2%6.6 $2.55 8/31/2023734,600 shares $1.95 million -2.6%5.6%5.9 $2.65 8/15/2023754,500 shares $1.97 million -4.9%5.7%4.6 $2.61 7/31/2023793,500 shares $2.20 million +5.6%6.2%4.3 $2.77 7/15/2023751,800 shares $2.29 million -11.6%5.8%3.4 $3.05 6/30/2023850,300 shares $2.17 million +4.7%6.6%3.1 $2.55 6/15/2023811,900 shares $2.58 million -4.7%6.3%1.9 $3.18 5/31/2023851,900 shares $2.56 million -10.5%6.6%2 $3.01 5/15/2023952,200 shares $2.73 million -17.2%7.4%2.3 $2.87 4/30/20231,150,000 shares $2.46 million -4.2%9.2%2.6 $2.14 4/15/20231,200,000 shares $2.35 million -2.4%9.7%2.7 $1.96Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. 3/31/20231,230,000 shares $2.00 million +21.8%9.9%3 $1.63 3/15/20231,010,000 shares $4.19 million +6.4%8.2%4.1 $4.15 2/28/2023949,000 shares $4.27 million +4.9%7.9%4.1 $4.50 2/15/2023904,900 shares $3.92 million +18.8%7.5%3.8 $4.33 1/31/2023761,600 shares $3.52 million +19.6%5.6%2.9 $4.62 1/15/2023636,700 shares $2.73 million +16.5%4.6%0.9 $4.29 12/30/2022546,500 shares $1.50 million -0.1%4.0%0.8 $2.74 12/15/2022547,000 shares $1.53 million -26.2%4.0%0.8 $2.79 11/30/2022740,900 shares $2.04 million -9.7%5.4%1.1 $2.75 11/15/2022820,100 shares $2.15 million +333.2%6.5%1.2 $2.62 10/31/2022189,300 shares $541,398.00 +68.3%1.5%0.2 $2.86 10/15/2022112,500 shares $441,000.00 -91.4%0.9%0.3 $3.92 9/30/20221,310,000 shares $517,581.00 -10.9%N/A0.3 $0.40 9/15/20221,470,000 shares $707,070.00 -17.0%N/A0.4 $0.48 8/31/20221,770,000 shares $822,696.00 +283.0%N/A0.5 $0.46 8/15/2022462,100 shares $596,109.00 +31.8%N/A0.1 $1.29 7/31/2022350,600 shares $232,588.04 +57.0%0.7%0.9 $0.66 7/15/2022223,300 shares $145,145.00 -38.2%0.4%0.6 $0.65 6/30/2022361,100 shares $203,479.85 -8.3%0.7%1 $0.56 6/15/2022393,800 shares $234,704.80 +0.8%0.8%1 $0.60 5/31/2022390,700 shares $308,653.00 -12.8%0.8%0.8 $0.79 5/15/2022448,000 shares $362,880.00 -35.5%0.9%0.8 $0.81 4/30/2022694,600 shares $632,086.00 -19.4%1.4%1.1 $0.91 4/15/2022861,800 shares $887,654.00 -3.5%1.8%1.2 $1.03 3/31/2022892,700 shares $999,824.00 +4.4%2.0%1.1 $1.12 3/15/2022855,100 shares $701,182.00 -20.1%1.9%0.8 $0.82 2/28/20221,070,000 shares $930,900.00 -8.6%2.8%1 $0.87 2/15/20221,170,000 shares $1.23 million +26.4%3.1%1.1 $1.05 1/31/2022925,400 shares $1.12 million +3.5%2.4%0.7 $1.21 1/15/2022894,100 shares $1.32 million +23.9%2.3%0.7 $1.48 12/31/2021721,600 shares $1.05 million -22.0%1.9%0.7 $1.46 12/15/2021925,100 shares $1.63 million -21.6%2.5%1 $1.76 11/30/20211,180,000 shares $2.60 million -4.1%3.2%1.4 $2.20 11/15/20211,230,000 shares $3.51 million +2.5%3.4%1.6 $2.85 10/29/20211,200,000 shares $2.87 million +1.7%3.4%2.8 $2.39 10/15/20211,180,000 shares $2.77 million -33.3%3.4%3 $2.35 9/30/20211,770,000 shares $5.31 million -31.4%5.1%4.6 $3.00 9/15/20212,580,000 shares $7.51 million -2.6%7.4%5.6 $2.91 8/31/20212,650,000 shares $8.48 million -0.8%7.6%5.7 $3.20 8/13/20212,670,000 shares $9.29 million -2.6%7.7%5.5 $3.48 7/30/20212,740,000 shares $9.97 million -9.9%7.9%5.4 $3.64 7/15/20213,040,000 shares $11.83 million +11.8%8.8%5.8 $3.89 6/30/20212,720,000 shares $12.62 million -20.0%7.9%5 $4.64 6/15/20213,400,000 shares $15.16 million +14.9%9.6%7.9 $4.46 5/28/20212,960,000 shares $13.26 million +11.3%8.4%7.1 $4.48 5/14/20212,660,000 shares $11.33 million +11.8%7.6%6 $4.26 4/30/20212,380,000 shares $12.14 million -8.5%7.8%4 $5.10 4/15/20212,600,000 shares $14.59 million +28.1%8.6%3.9 $5.61 3/31/20212,030,000 shares $11.65 million -12.5%6.9%2.7 $5.74 3/15/20212,320,000 shares $16.26 million +9.4%7.9%2.7 $7.01Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. 2/26/20212,120,000 shares $14.37 million -12.4%7.4%2.3 $6.78 2/12/20212,420,000 shares $20.04 million -12.6%8.5%2.5 $8.28 1/29/20212,770,000 shares $16.45 million -9.2%9.5%3.2 $5.94 1/15/20213,050,000 shares $21.75 million -5.0%10.6%3.8 $7.13 12/31/20203,210,000 shares $17.17 million -0.6%10.6%4.2 $5.35 12/15/20203,230,000 shares $19.19 million +1.9%10.7%4.6 $5.94 11/30/20203,170,000 shares $20.16 million +1.3%11.3%4.1 $6.36 10/30/20202,730,000 shares $11.55 million -10.2%10.1%1.8 $4.23 10/15/20203,040,000 shares $11.89 million -8.2%11.4%1.8 $3.91 9/30/20203,310,000 shares $11.45 million -6.0%12.4%2 $3.46 9/15/20203,520,000 shares $12.43 million -1.4%13.2%2.2 $3.53 8/31/20203,570,000 shares $11.21 million -40.6%12.8%2.4 $3.14 8/14/20206,010,000 shares $74.70 million +11.7%22.8%4.4 $12.43 7/31/20205,380,000 shares $50.73 million +6.1%20.4%9.9 $9.43 7/15/20205,070,000 shares $39.04 million +1.2%20.4%14.3 $7.70 6/30/20205,010,000 shares $43.49 million +7.3%20.1%16.1 $8.68 6/15/20204,670,000 shares $39.41 million +8.1%18.6%16.2 $8.44 5/29/20204,320,000 shares $35.34 million +1.2%17.2%16.5 $8.18 5/15/20204,270,000 shares $27.80 million +1.4%17.0%18.5 $6.51 4/30/20204,210,000 shares $29.18 million -1.2%17.2%19.9 $6.93 4/15/20204,260,000 shares $26.24 million +1.7%18.2%20.2 $6.16 3/31/20204,190,000 shares $24.30 million -14.3%17.9%19 $5.80 3/13/20204,890,400 shares $31.10 million -12.0%25.7%16.7 $6.36 2/28/20205,560,000 shares $30.86 million +2.4%29.2%27.5 $5.55 2/14/20205,430,000 shares $29.92 million +2.8%28.5%27 $5.51 1/31/20205,280,000 shares $33.42 million +2.3%24.8%24.6 $6.33 1/15/20205,160,000 shares $33.18 million +4.5%24.2%24.1 $6.43 12/31/20194,940,000 shares $34.14 million +2.9%23.2%19.2 $6.91 UBX Short Interest - Frequently Asked Questions What is Unity Biotechnology's current short interest? Short interest is the volume of Unity Biotechnology shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 258,400 shares of UBX short. 1.68% of Unity Biotechnology's shares are currently sold short. Learn More on Unity Biotechnology's current short interest. What is a good short interest ratio for Unity Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UBX shares currently have a short interest ratio of 5.0. Learn More on Unity Biotechnology's short interest ratio. What is a good short interest percentage for Unity Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.68% of Unity Biotechnology's floating shares are currently sold short. Is Unity Biotechnology's short interest increasing or decreasing? Unity Biotechnology saw a decrease in short interest during the month of November. As of November 30th, there was short interest totaling 258,400 shares, a decrease of 10.2% from the previous total of 287,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Unity Biotechnology's float size? Unity Biotechnology currently has issued a total of 16,850,000 shares. Some of Unity Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Unity Biotechnology currently has a public float of 15,370,000 shares. How does Unity Biotechnology's short interest compare to its competitors? 1.68% of Unity Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Unity Biotechnology: Aerovate Therapeutics, Inc. (9.14%), ESSA Pharma Inc. (1.56%), Unicycive Therapeutics, Inc. (0.98%), PDS Biotechnology Co. (10.37%), Theratechnologies Inc. (0.23%), Annovis Bio, Inc. (9.49%), OptiNose, Inc. (4.88%), Repare Therapeutics Inc. (2.00%), Vistagen Therapeutics, Inc. (1.70%), InterCure Ltd. (0.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Unity Biotechnology stock? Short selling UBX is an investing strategy that aims to generate trading profit from Unity Biotechnology as its price is falling. UBX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Unity Biotechnology? A short squeeze for Unity Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UBX, which in turn drives the price of the stock up even further. How often is Unity Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UBX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Aerovate Therapeutics Short Squeeze ESSA Pharma Short Squeeze Unicycive Therapeutics Short Squeeze PDS Biotechnology Short Squeeze Theratechnologies Short Squeeze Annovis Bio Short Squeeze OptiNose Short Squeeze Repare Therapeutics Short Squeeze Vistagen Therapeutics Short Squeeze InterCure Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UBX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unity Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unity Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UBX Stock Alerts